Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
Year: 2008
Type: editorial
Abstract: Determining the status of breast cancer surface receptors (estrogen receptor, progesterone receptor, HER2/neu) has become routine in the care of patients with this disease and has proven to be helpful in guiding treatment. For this reason, breast cancer has become a model for molecularly guided therapy in solid tumors. Emerging data support that these receptors are associated with risk for developing brain metastases. Additionally, once brain metastases have occurred these receptors may also correlate with prognosis.
Source: Breast Cancer Research
DOI: 10.1186/bcr1868
Authors: Jai Grewal, Santosh Kesari
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W2122538927
